Immunotherapy Combination Demonstrates Benefit in Small, Early Trial of Melanoma
A small, early trial demonstrated that a combination of Imlygic and Keytruda can have clinical benefit for patients with advanced melanoma.
Questions Remain in Identifying Mutations in Non-Lynch Syndrome Patients With Colorectal Cancer
While inherited factors do play a role in many people getting colorectal cancer, researchers are still unsure how to identify these mutations.